Previous close | 440.90 |
Open | 445.50 |
Bid | 449.30 x 10000 |
Ask | 449.95 x 10000 |
Day's range | 445.50 - 445.50 |
52-week range | 307.15 - 450.70 |
Volume | |
Avg. volume | 49 |
Market cap | 115.525B |
Beta (5Y monthly) | 0.41 |
PE ratio (TTM) | 31.05 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We recently compiled a list of the 11 Best Feminist Stocks To Invest In. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other feminist stocks. With the passage of time, the role of women in the modern day workplace has slowly started to grow. […]
On June 12, 2024, Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 2,280 shares of the company.
Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $475.79, signifying a -1.19% move from its prior day's close.